Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2014
09/11/2014US20140256626 Peg conjugates of exenatide
09/11/2014US20140256623 Transmucosal delivery of pharmaceutical active substances
09/11/2014US20140256622 Exogenously triggered controlled release materials and uses thereof
09/11/2014US20140256617 In Situ Forming Hydrogel and Method Using Same
09/11/2014US20140256612 Antibiotic conjugates directly linked with steroid drugs
09/11/2014US20140256017 Saccharide-containing protein conjugates and uses thereof
09/11/2014US20140255525 Beverages with compositions of vinegar
09/11/2014US20140255516 Method of using peelable film-forming composition
09/11/2014US20140255515 Liquid compositions of calcium acetate
09/11/2014US20140255505 Pazopanib Formulation
09/11/2014US20140255504 Enhancement of the efficacy of therapeutic proteins
09/11/2014US20140255498 Pharmaceutical nanosuspension
09/11/2014US20140255497 Organic Compounds
09/11/2014US20140255496 Micronized placental tissue compositions and methods of making and using the same
09/11/2014US20140255495 Colon lavage system
09/11/2014US20140255493 Extrudate and methods of using said extrudate
09/11/2014US20140255488 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
09/11/2014US20140255487 Dosage form for insertion into the mouth
09/11/2014US20140255479 Pharmaceuticals for Oral Delivery
09/11/2014US20140255466 Composition for enhancing transdermal absorption of drug and patch preparation
09/11/2014US20140255411 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
09/11/2014US20140255400 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use
09/11/2014US20140255379 Stabilized compositions against ionising radiation
09/11/2014US20140255377 Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment
09/11/2014US20140255376 Regulation of Specific Spinal Neurons Regulating Pain Transmission
09/11/2014US20140255374 Compositions and methods for treatment of autoimmune and other disease
09/11/2014US20140255367 Sweetening and Healthy Compositions and Methods Associated Therewith
09/11/2014US20140255366 Novel compositions
09/11/2014US20140255349 Peptides with viral infection enhancing properties and their use
09/11/2014US20140255322 Siloxane polymer and actives
09/11/2014US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
09/11/2014US20140255314 Method for inducing physiological adjustment using high density display of material
09/11/2014US20140255311 Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide
09/11/2014US20140255304 Tdp-43 specific binding molecules
09/11/2014US20140255300 FAP-Activated Proteasome Inhibitors for Treating Solid Tumors
09/11/2014CA2845165A1 Composition for enhancing transdermal absorption of drug and patch preparation
09/10/2014EP2775302A1 Compound-carrier systems for assays in nematodes
09/10/2014EP2774953A1 Gelatable compositions
09/10/2014EP2774624A1 Amatoxin derivatives
09/10/2014EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
09/10/2014EP2774608A1 Drug loaded polymeric nanoparticles and methods of making and using same
09/10/2014EP2774605A1 Pharmaceutical composition comprising almotriptan malate having uniform drug distribution and potency
09/10/2014EP2773675A1 Quick-acting insulin formulation including an oligosaccharide
09/10/2014EP2773426A1 Combinational liposome compositions for cancer therapy
09/10/2014EP2773379A2 Subcutaneous delivery of polymer conjugates of therapeutic agents
09/10/2014EP2773378A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids)
09/10/2014EP2773377A1 Glp-1 receptor agonist peptide gastrin conjugates
09/10/2014EP2773376A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof
09/10/2014EP2773375A1 Tyrosine based linkers for the releasable connection of peptides
09/10/2014EP2773369A1 Compositions and methods for preventing and treating oral diseases
09/10/2014EP2773346A1 Pharmaceutical compositions of hydrophobic camptothecin derivatives
09/10/2014EP2773344A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts
09/10/2014EP2773333A1 Dermal delivery compositions and methods
09/10/2014EP2773331A1 Formulations for the treatment of diabetes
09/09/2014US8829163 Liquid formulations for long-acting erythropoietin conjugate
09/09/2014US8829159 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
09/09/2014US8829109 Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery
09/09/2014US8829072 Biomaterial containing degradation stabilized polymer
09/09/2014US8829054 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
09/09/2014US8829046 3-methanesulfonylpropionitrile for treating inflammation and pain
09/09/2014US8829020 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
09/09/2014US8828993 Psychotropic agents having glutamate NMDA activity
09/09/2014US8828980 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
09/09/2014US8828979 Salicylic acid gel
09/09/2014US8828975 Phosphate-containing nanoparticle delivery vehicle
09/09/2014US8828972 Formulations containing alkylphosphocholines using novel negative charge carriers
09/09/2014US8828956 Carbohydrate conjugates as delivery agents for oligonucleotides
09/09/2014US8828947 Polypeptide formulation
09/09/2014US8828925 Etoposide and doxorubicin conjugates for drug delivery
09/09/2014US8828923 Insulin derivatives
09/09/2014US8828698 Immobilized angiogenin mixtures and uses thereof
09/09/2014US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor
09/09/2014US8828444 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel
09/09/2014US8828443 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
09/09/2014US8828442 Pharmaceutical solid dispersions
09/09/2014US8828438 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase
09/09/2014US8828437 Thermogelling anaesthetic compositions
09/09/2014US8828436 Methods and compositions for treating tissue using silk proteins
09/09/2014US8828431 Solid oral dosage form containing an enhancer
09/09/2014US8828430 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/09/2014US8828428 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
09/09/2014US8828425 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
09/09/2014US8828422 Stabilized liquid egg material for extended shelf life
09/09/2014US8828421 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
09/09/2014US8828405 Method to enhance an immune response of nucleic acid vaccination
09/09/2014US8828403 Anti-tumor immunotherapy
09/09/2014US8828401 Cytotoxic peptides and antibody drug conjugates thereof
09/09/2014US8828383 Nanocarriers with multi-photon response elements
09/09/2014US8828373 Polyalkylene glycol derivative and modified bio-related substance
09/09/2014US8828359 Particulate materials
09/09/2014US8828354 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
09/09/2014CA2781766C Method of stabilizing reduced coenzyme q10
09/09/2014CA2511718C Tablet excipient
09/04/2014WO2014134509A2 Peptide-and amine-modified glucan particles for delivery of therapeutic cargoes
09/04/2014WO2014134486A2 Conjugates comprising cell-binding agents and cytotoxic agents
09/04/2014WO2014134483A2 Conjugates comprising cell-binding agents and cytotoxic agents
09/04/2014WO2014134457A2 Conjugates comprising cell-binding agents and cytotoxic agents
09/04/2014WO2014134427A1 Controlling the bioavailability of active ingredients in topical formulations
09/04/2014WO2014134286A2 Cerium oxide nanoparticles accelerate the decay of peroxynitrite (onoo-)
09/04/2014WO2014134049A1 Delayed release film coatings containing calcium silicate and substrates coated therewith
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 1712